The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens.

ARTAC M., BOZCUK H., Pehlivan S., AKCAN S., PEHLIVAN M., SEVER T., ...Daha Fazla

Journal of cancer research and clinical oncology, cilt.136, ss.803-9, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 136
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1007/s00432-009-0720-3
  • Dergi Adı: Journal of cancer research and clinical oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.803-9
  • Anahtar Kelimeler: Colorectal cancer, Irinotecan, XPD, XRCC1, Single nucleotide polymorphisms, Overall survival, MULTIVARIATE-ANALYSIS, STRAND BREAKS, CANCER, CHEMOTHERAPY, GENE, REPAIR, CAPECITABINE, OXALIPLATIN, COMBINATION, TOXICITY
  • İstanbul Üniversitesi Adresli: Hayır